Skyrizi

Skyrizi Caution For Usage

risankizumab

Manufacturer:

Abbvie

Distributor:

Zuellig Pharma
Full Prescribing Info
Caution For Usage
Incompatibilities: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
Special precautions for disposal and other handling: Before injecting, patients should remove the carton from the refrigerator and allow to reach room temperature out of direct sunlight (30 to 90 minutes) without removing the pre-filled pen from the carton.
The solution should be colourless to yellow and clear to slightly opalescent.
General special precautions: Prior to use, a visual inspection of each pre-filled pen is recommended. The solution may contain a few translucent to white product-related particles. Skyrizi should not be used if the solution is cloudy or discoloured, or contains large particles. Do not shake the pre-filled pen.
Comprehensive instructions for use are provided in the package leaflet.
Each pre-filled pen is for single use only.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in